Back to search

Article

Aspartate-β-hydroxylase as a promising prognostic and therapeutic biomarker for HBV-positive hepatocellular carcinoma

2023-06-05

Abstract excerpt

BACKGROUND: Hepatitis B virus (HBV) is a key factor in the development of hepatocellular carcinoma (HCC). However, effective treatments to improve prognosis are still lacking. Aspartate plays a critical role not only in tumor cell proliferation, invasion, and migration, but also in the tumor immune microenvironment. A deeper understanding of the cellular and molecular mechanisms of HBV-positive HCC in terms of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e5171011-e5b6-5b1f-8cff-6a15411f6d32
DOI
10.21203/rs.3.rs-2984696/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aspartate-β-hydroxylase as a promising prognostic and therapeutic biomarker for HBV-positive hepatocellular carcinomaDOI 10.21203/rs.3.rs-2984696/v1
Select a neighboring publication to make it the new centre.